Healthcare in politics, week 12Read more...
Healthcare in politics, week 10
Healthcare has been hot button a political issue for decades, with fights over Medicare going back to the mid-60s. The issue has been especially fractious over the last decade with the implementation of the Affordable Care Act, which passed without a single Republican voting for it.
It's with that backdrop that we now find ourselves in the midst of what HHS declared on January 31, 2020 to be a public health emergency. COVID-19 has upended the healthcare system in ways that nobody could have foreseen; thanks, in part, to CMS waiving telehealth regulations in April, combined with the necessity of using virtual care to see a doctor, that sector has been explosive growth in just a few months.
As this is an election year, the delineations between what the two sides believe in, and their vision for how healthcare should work, will be made clear. That is what will be discussed at the Healthcare in Politics salon, hosted by Vator, HP and UCSF Healthhub, on October 7. Every week until then we will be doing a roundup of some of the biggest healthcare news and what Trump, Biden and the biggest healthcare agencies are up to: AstraZeneca halts vaccine trial, pharma companies pledge commitment to safety
AstraZeneca, one of the companies that is developing a COVID-19 vaccine, but clinical trials worldwide were put on hold while the company investigated an adverse reaction in a trial participant in the United Kingdom.
It was not known at first what the person's exact reaction was, though it was later revealed that the patient experienced neurological symptoms consistent with transverse myelitis, a spinal inflammatory disorder.
"We are working to expedite the review of the single event to minimize any potential impact on the trial timeline," AstraZeneca said in a statement.
"This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials."
This news comes as the Trump administration is telling states to get ready for a vaccine before election day; meanwhile most Americans say they won't take a COVID-19 vaccine before the election, including 85 percent of Democrats, 61 percent of independents and 35 percent of Republicans.
As a vaccine potentially becomes politicized the CEOs of nine pharma companies, AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer and Sanofi all signed a pledge to commit to make safety an integral part of the COVID vaccine process.
"We, the undersigned biopharmaceutical companies, want to make clear our on-going commitment to developing and testing potential vaccines for COVID-19 in accordance with high ethical standards and sound scientific principles," the pledge states. Trump takes heat for COVID comments
In audio tapes from an interview with journalist Bob Woodward, President Donald Trump admitted he as far back as February that COVID-19 was "more deadly than even your strenuous flus," despite public comments to the contrary, in which he said the virus was "going to disappear" and "all work out fine.
In the interview, Trump said that the coronavirus was perhaps five times "more deadly" than the flu.
"I wanted to always play it down," he told Woodward. "I still like playing it down, because I don't want to create a panic."
Trump also said that young people were more likely to get the virus than was known at the time.
"Just today and yesterday, some startling facts came out. It's not just old, older. Young people too, plenty of young people," Trump said.
Despite saying all of this in private, Trump's public statements have often express the opposite view. On April 3, during a coronavirus task force briefing, Trump stated that the virus would go away, yet on April 5 he told Woodward, "It's a horrible thing. It's unbelievable," and on April 13, he said, "It's so easily transmissible, you wouldn't even believe it."
A bill brought to the floor of the Senate for a $500 billion COVID relief package was voted down 52-47, failing to get the 60 votes needed to advance. Kentucky Senator Rand Paul was the only Republican to vote against the bill.
The bill provides $300 per week in federal unemployment benefits through Dec. 27, another round of Paycheck Protection Program (PPP) funding, more money for testing and schools and liability protections from coronavirus-related lawsuits. It also included a tax credit and language allowing for hundreds of billions from the previous COVID relief bill to be recouped.
Majority leader McConnell and Senate Minority Leader Charles Schumer blasted each other on the Senate floor.
“Senators who share the Democratic leader’s toxic attitude, who think the real enemy are their political opponents, I assume will follow his lead and vote no. They can tell American families they care more about politics than helping them,” McConnell said.
“It is laden with poison pills. Provisions our colleagues know Democrats would never support to guarantee the bill’s failure. The truth of the matter is the Republicans and the Republican leader don’t want to pass a bill too many on the hard right in the Senate and outside it would be angry,” said Schumer.
The House had previously passed a $3.4 trillion billion, and Democrats have offered to come down to $2.2 trillion. Republicans unveiled their own bill in July, priced at $1.1 trillion. Public trust in Fauci and CDC falls
A poll from the Kaiser Family Foundation found that while the CDC and Anthony Fauci are still the most trusted information sources about COVID, the numbers for both have fallen sharply since April.
In all, 68 percent now say they have at least a fair amount of trust in Fauci, and 67 percent say they trust the CDC.
That represents a 16 point drop for trust in the CDC since April, while trust in Fauci has dropped 10 points in that time. Republicans, in particular, have lost faith in both, going from 90 percent to 60 percent trust in the CDC, and from 77 percent to 48 percent for Fauci. While trust in the CDC has fallen across the political spectrum, dropping 86 percent to 74 percent among Democrats, and 81 percent to 70 percent among independents, trust in Fauci has gone up among Democrats, 80 percent to 86 percent over the past six months. 71 percent of independents say they trust him, down from 76 percent.
Meanwhile, 53 percent say that trust Dr. Deborah Birx as a source for information about COVID, while 52 percent trust Joe Biden and 40 percent say they trust Trump.
(Image source: udemycdn.com)
Read more from our "The Future of Healthcare" series
We have a great array of guests from both sides of the aisle and from around the countryRead more...
Healthcare in politics, week 11Read more...